ArticleFrontiers in oncology2025
A two-stage deep learning prediction system for colon cancer microsatellite instability status using CT images.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study seeks to build a two-stage deep learning approach for identifying the microsatellite instability (MSI) status of colon cancer based on computed tomography (CT) scans without the requirement for manual segmentation. Methods: This study included 108 enhanced CT scans of colon cancer, including 68 cases of ascending colon, 14 cases of transverse colon, 18 cases of descending colon, and 8 cases of sigmoid colon; there were 56 cases of MSI-H and 52 cases of microsatellite stability (MSS). In the first stage, the segmentation model MSI-SAM was trained to accurately segment the lesion locations in the CT scans. In the second stage, the mask acquired from the MSI-SAM segmentation was multiplied by the original CT image (CT_Origin) bitwise, and the result was merged with the mask obtained from the MSI-SAM segmentation (Segment) to obtain CT_ROI. Both CT_ROI and CT_Origin were then diagnosed using the colon cancer MSI status diagnosis model. Results: The performance of the suggested CT segmentation model MSI-SAM in the ascending colon, transverse colon, descending colon, and sigmoid colon areas (DSC: IoU) was (0.886:0.798), (0.878:0.783), (0.923:0.857), and (0.854:0.747), respectively. The AUC of the MSI status diagnostic model for patients with colon cancer was 0.935 (95% CI 0.892-0.947), the ACC was 0.913, the sensitivity was 1.000, and the specificity was 0.846. Conclusions: The segmentation masks created by the trained deep learning segmentation model achieved a level comparable to that of expert radiologists, and the deep learning diagnostic model played an essential role in supporting doctors in diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.